Ovarian Volume in Korean Women with Polycystic Ovary Syndrome and Its Related Factors
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: The aim of this study was to determine the relationship of ovarian volume (OV) to age, height, and weight in Koreanyoung women with the polycystic ovary syndrome (PCOS) undergoing ultrasonography (US) and to investigate the relationshipbetween ovarian follicle count and volume on US and serum hormone levels including the levels of the anti-Müllerian hormone(AMH) and gonadotropin. Methods: A total of 272 Korean nulliparous women aged 15 to 39 years who were newly diagnosed with PCOS at a universityhospital were included in this study. Evaluation of the ovaries and measurement of OVs in all cases were randomly performed byultrasound. The OV and follicle number (FN) were obtained in all cases. Results: In Korean women with PCOS, mean OV was 7.9 ± 3.6 cm3 (right) and 6.7 ± 3.1 cm3 (left). Mean FN in the PCOS groupwas 14.2 ± 4.6 (right) and 13.8 ± 4.3 (left). OV and ovarian FN were unrelated to patient weight, height and body mass index. Theleft ovarian FN was related to patient age. AMH levels ranged from 5.31 to 43.1 ng/mL and the mean level was 13.9 ± 7.2 ng/mL. Serum AMH was related to OV and FN, and serum total testosterone was related to FN in Korean women with PCOS. Conclusions: In Korean nulliparous women with PCOS, OV was smaller than that in other ethnic groups and the right OVwas larger than the left OV. Ovarian FN, AMH, testosterone are good markers for the diagnosis of PCOS in Korean women. (JMenopausal Med 2017;23:25-31)
Abstract
Objectives: The aim of this study was to determine the relationship of ovarian volume (OV) to age, height, and weight in Koreanyoung women with the polycystic ovary syndrome (PCOS) undergoing ultrasonography (US) and to investigate the relationshipbetween ovarian follicle count and volume on US and serum hormone levels including the levels of the anti-Müllerian hormone(AMH) and gonadotropin. Methods: A total of 272 Korean nulliparous women aged 15 to 39 years who were newly diagnosed with PCOS at a universityhospital were included in this study. Evaluation of the ovaries and measurement of OVs in all cases were randomly performed byultrasound. The OV and follicle number (FN) were obtained in all cases. Results: In Korean women with PCOS, mean OV was 7.9 ± 3.6 cm3 (right) and 6.7 ± 3.1 cm3 (left). Mean FN in the PCOS groupwas 14.2 ± 4.6 (right) and 13.8 ± 4.3 (left). OV and ovarian FN were unrelated to patient weight, height and body mass index. Theleft ovarian FN was related to patient age. AMH levels ranged from 5.31 to 43.1 ng/mL and the mean level was 13.9 ± 7.2 ng/mL. Serum AMH was related to OV and FN, and serum total testosterone was related to FN in Korean women with PCOS. Conclusions: In Korean nulliparous women with PCOS, OV was smaller than that in other ethnic groups and the right OVwas larger than the left OV. Ovarian FN, AMH, testosterone are good markers for the diagnosis of PCOS in Korean women. (JMenopausal Med 2017;23:25-31)
참고문헌 (23)
- Homburg R, "Polycystic ovary syndrome", Best Pract Res Clin Obstet Gynaecol, 22, pp.261~274 (2008)
- Hsu MI, "Changes in the PCOS phenotype with age", Steroids, 78, pp.761~766 (2013)
- Welt CK, "Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations", J Clin Endocrinol Metab, 91, pp.4361~4368 (2006)
- Ehrmann DA, "Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome", J Clin Endocrinol Metab, 90, pp.66~71 (2005)
- Kumar A, "Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)", Clin Endocrinol (Oxf), 62, pp.644~649 (2005)
- Carmina E, "Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters", J Clin Endocrinol Metab, 90, pp.2545~2549 (2005)
- Carmina E, "Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?", Am J Obstet Gynecol, 167, pp.1807~1812 (1992)
- Vink JM, "Heritability of polycystic ovary syndrome in a Dutch twinfamily study", J Clin Endocrinol Metab, 91, pp.2100~2104 (2006)
- Kelsey TW, "Ovarian volume throughout life: a validated normative model", PLoS One, 8, pp.e71465~ (2013)
- Alsamarai S, "Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age", J Clin Endocrinol Metab, 94, pp.4961~4970 (2009)
- Christensen JT, "Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception", Acta Obstet Gynecol Scand, 76, pp.784~789 (1997)
- Ng EH, "Effects of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility", Hum Reprod, 18, pp.2169~2174 (2003)
- Zhang HY, "Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a largescale case-control study", Arch Gynecol Obstet, 287, pp.525~531 (2013)
- Yeh HC, "Polycystic ovarian disease: US features in 104 patients", Radiology, 163, pp.111~116 (1987)
- Atiomo WU, "Ultrasound criteria in the diagnosis of polycystic ovary syndrome (PCOS)", Ultrasound Med Biol, 26, pp.977~980 (2000)
- Köşüş N, "Do threshold values of ovarian volume and follicle number for diagnosing polycystic ovarian syndrome in Turkish women differ from western countries?", Eur J Obstet Gynecol Reprod Biol, 154, pp.177~181 (2011)
- Da Eun Lee, "Diagnostic Usefulness of Transrectal Ultrasound Compared with Transvaginal Ultrasound Assessment in Young Korean Women with Polycystic Ovary Syndrome", 대한폐경학회지, 21(3), pp.149~154 (2015), 대한폐경학회
- 유시연, "다낭성 난소증후군의 항뮐러관 호르몬에 관한 연구", Obstetrics & Gynecology Science, 55(05), pp.315~324 (2012), 대한산부인과학회[DOI]
- Ji Hee Yoo, "Age specific serum anti-Müllerian hormone levels in 1,298 Korean women with regular menstruation", Clinical and Experimental Reproductive Medicine, 38(2), pp.93~97 (2011), 대한생식의학회
- La Marca A, "Anti-Mullerian hormone (AMH): what do we still need to know?", Hum Reprod, 24, pp.2264~2275 (2009)
- Wachs DS, "Serum antimullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women", J Clin Endocrinol Metab, 92, pp.1871~1874 (2007)
- Carlsen SM, "Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome", Hum Reprod, 24, pp.1732~1738 (2009)
- Robinson S, "Which hormone tests for the diagnosis of polycystic ovary syndrome?", Br J Obstet Gynaecol, 99, pp.232~238 (1992)